A New Objective Titration Procedure for the Treatment of Mandibular Advancement Device in OSAHS Patients

Last updated: May 20, 2024
Sponsor: Beijing Jishuitan Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sleep Apnea Syndromes

Treatment

titration procedure for MAD treatment

Clinical Study ID

NCT06424405
BeijingJH
  • Ages 18-70
  • All Genders

Study Summary

The aim of this clinical trial is to apply a new objective titration procedure in obstructive sleep apnea hypopnea syndrome (OSAHS) patients treated with mandibular advancement device (MAD), and to compare this new objective titration procedure with the subjective titration procedure which is commonly used in clinical practice. The remotely intelligent sleep monitoring system (RISMS) will be used in the new objective titration procedure. The main questions it aims to answer are:

  1. The efficacy of MAD therapy after each titration procedure.

  2. The titration time efficiency and the improvement of subjective symptoms after each titration procedure.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • OSAHS patients with AHI≥15

  • 18≤age≤70 years;

  • Subject is capable of giving informed consent

  • refusal of or noncompliance with CPAP (continuous positive airway pressure) orunwilling to undergo upper airway surgery

  • Normal clinical, periodontal and temporomandibular joint examination

Exclusion

Exclusion Criteria:

  • Active periodontal problems including tooth mobility

  • active temporomandibular joint dysfunction

  • Edentulous patients or Insufficient teeth to support MAD

  • patients with severe unstable systemic diseases or suffering from psychiatricdisorders

  • Enlarged palatine tonsils (Friedman grade IV tonsils)

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: titration procedure for MAD treatment
Phase:
Study Start date:
April 25, 2024
Estimated Completion Date:
March 31, 2025

Study Description

In this study, patients diagnosed with OSAHS and referred for MAD treatment will be recruited. The amount of mandibular protrusion seems to be a key factor in the treatment of MAD. Patients will experience either of the two titration procedures to obtain the optimal mandibular protrusion. One procedure is a new objective titration procedure which will use the RISMS for the treatment of MAD, which will help the clinician instruct the titration according the objective therapeutic indicator. The other procedure is the subjective titration procedure which is commonly used in clinical practice. Finally, the researchers will compare the efficacy of the MAD therapy, the titration time efficiency and the improvement of subjective symptoms between the two titration procedures.

Connect with a study center

  • Beijing Jishuitan Hospetal

    Beijing, Beijing 100035
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.